Effect of a common X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) on the occurrence of premature myocardial infarction and stenotic atherosclerosis requiring revascularization

Atherosclerosis

Volumn 195, Issue 1, 2007, Pages

  Alfakih, K ^a   Brown, B ^a   Lawrance, R A ^a   Warburton, P ^b   Maqbool, A ^b   Walters, K ^c   Samani, N J ^d   Ball, S G ^a   Balmforth, A J ^b   Hall, A S ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Angiotensin; Coronary disease; Genetics; Molecular biology

Indexed keywords

ANGIOTENSIN 2 RECEPTOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVASCULARIZATION; STATISTICAL SIGNIFICANCE; STENOSIS;

AGED; ATHEROSCLEROSIS; CHROMOSOMES, HUMAN, X; CONSTRICTION, PATHOLOGIC; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 34548775047     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.01.028     Document Type: Article

References (26)

1. Pajukanta P., Cargill M., Viitanen L., et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 67 (2000) 1481-1493
2. Samani N.J., Burton P., Mangino M., et al. BHF Family Heart Study Research Group. A genomewide linkage study of 1933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family heart study. Am J Hum Genet 77 (2005) 1011-1020
3. Alfakih K., Maqbool A., Sivananthan M., et al. LV mass index and the common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) in patients with systemic hypertension. Hypertension 43 (2004) 1189-1194
4. Alfakih K., Lawrance R.A., Maqbool A., et al. The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) in a cohort of 509 families with premature coronary artery disease. Eur Heart J 26 (2005) 584-589
5. Strauss M.H., and Hall A.S. Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation 22 114 (2006) 838-854
6. Stoll M., Steckelings U.M., Paul M., et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Investig 95 (1995) 651-657
7. Wu L., Iwai M., Nakagami H., et al. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104 (2001) 2716-2721
8. Iwai M., Chen R., Li Z., et al. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 112 (2005) 1636-1643
9. Brassard P., Amiri F., and Schiffrin E.L. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Hypertension 46 (2005) 598-606
10. Ma J., Nishimura H., Fogo A., et al. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 53 (1998) 937-944
11. Ferroni P., Basili S., Martini F., et al. Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation. J Investig Med 51 (2003) 295-300
12. Schieffer B., Bunte C., Witte J., et al. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J Am Coll Cardiol 44 (2004) 362-368
13. Kim M.P., Zhou M., and Wahl L.M. Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: Implications for atherosclerotic plaque rupture. J Leukoc Biol 78 (2005) 195-201
14. Nishimura H., Yerkes E., Hohenfellner K., et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 3 (1999) 1-10
15. Erdmann J., Guse M., Kallisch H., Fleck E., and Regitz-Zagrosek V. Novel intronic polymorphism (+1675G/A) in the human angiotensin II subtype 2 receptor gene. Hum Mutat 15 (2000) 487
16. Warnecke C., Willich T., Holzmeister J., Bottari S.P., Fleck E., and Regitz-Zagrosek V. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements. Biochem J 340 (1999) 17-24
17. Warnecke C., Mugrauer p, Surder D., et al. The intronic angiotensin II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing. Am J Physiol Regul Integr Comp Physiol 289 (2005) R1729-R1735
18. Topol E. The genetics of heart attack. Heart 92 (2006) 855-861
19. Horvath S., Laird N.M., and Knapp M. The transmission/disequilibrium test and parental-genotype reconstruction for X-chromosomal markers. Am J Hum Genet 66 (2000) 1161-1167
20. Witte J.S., Gauderman W.J., and Thomas D.C. Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol 149 (1999) 693-705
21. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
22. Virchow RLK. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Frankfurt am Main, Von Meidinger and Sohn, 1856. Contains: Thrombose und Embolie. Gefässentzündung und septische Infektion. In: Matzdorff AC, Bell WR, English translators. Thrombosis and Emboli, Canton. Massachusetts: Science History Publications; 1998, p. 219-732.
23. Sales V.L., Sukhova G.K., Lopez-Ilasaca M.A., Libby P., Dzau V.J., and Pratt R.E. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 112 (2005) 3328-3336
24. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
25. Davies M.J. The pathophysiology of acute coronary syndromes. Heart 83 (2000) 361-366
26. Shah P.K., Falk E., Badimon J.J., et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92 (1995) 1565-1569